Blog
Stay up-to-date on news and events in the transplantation community
Categories:
Business Wire—Organ Recovery Systems’ LifePort Liver Transporter Preserves First Livers for Transplant as Part of the PILOT Continued Access Study
LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States. We are proud to announce...
Business Wire—LifePort Kidney Transporter Awarded Exclusive Contract for Kidney Transplant Preservation Services in Belgium
We are proud to announce that the first kidney has officially been pumped using the LifePort Kidney Transporter in Belgium under a newly signed contract that names Organ Recovery Systems as the exclusive provider of kidney preservation services at seven transplant...
Machine Perfusion in Liver Transplantation: A Systematic Review and Meta-Analysis
A systematic review and meta-analysis by Jakubauskas et al. aimed to review the literature reporting liver transplant outcomes when using normothermic machine perfusion (NMP) or hypothermic machine perfusion (HMP) for organ preservation compared to static cold storage...
MedTech Insight—Organ Transplant Surgery Has Advanced – Organ Storage Should Too
In this article, MedTech Insight highlights machine preservation of donor organs with LifePort technology. By increasing utilization of donor organs and transporting them longer distances, LifePort systems may aid clinicians to make access to transplant more equitable...
Saint-Luc—World first: new technique for preserving kidney grafts
We are proud to announce that Cliniques universitaires Saint-Luc transplanted the first kidney perfused in the LifePort Kidney Transporter after introducing supplemental oxygen! The link showcases an interview in French with kidney transplant surgeon Professor Tom...
Hypothermic Machine Perfusion as a National Standard Preservation Method for Deceased Donor Kidneys
An article published in Transplantation by Brat et al. presented the evaluation of a 2-year project to implement continuous nonoxygenated hypothermic machine perfusion (HMP) as standard of care for all types of deceased donor kidneys in the Netherlands. The...
Discover Magazine—The People Making Organ Transplants More Efficient
In this article, Discover Magazine highlights how companies, such as Organ Recovery Systems, are transforming the way donated organs are preserved and transported. We're grateful to share our story, especially during National Donate Life Month! With the LifePort...
Hypothermic machine perfusion for liver graft preservation
LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States. A recent review article by...
Outcome of liver transplantation with grafts from DBD donors treated with D-HOPE
In a single center, retrospective cohort study by Patrono et al., they sought to compare the effects of dual hypothermic oxygenated machine perfusion (D-HOPE) and static cold storage (SCS) on graft survival in liver transplant with grafts from extended criteria...
Intermountain Healthcare—Days of Using Coolers to Transport Organs May Soon Be Over
LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States. In this article,...
Fox19—UC Health Performs First Cold Pump Liver Transplant
LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States. In this article from FOX19...
KSLTV—Doctors Testing New Liver Transplant Transport System
LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States. In this article, KSLTV of...
University Hospital—University Hospital Performs First Transplant with Machine Preserved Liver in the State of New Jersey
LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States. In this press release,...
Gift of Life Howie’s House—Supporter Spotlight
In this article from Gift of Life Howie's House (formerly Family House), learn how Organ Recovery Systems proudly supports Howie's House and its mission to serve as a “Home Away from Home” for transplant families. “Supporting the transplant community is something I...
UNOS Insights—The Hypothermic Option
LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States. In this UNOS Insights...
HMP of Kidneys Compensates for Extended Storage Time: A Single Intervention With a Significant Impact
A study out of Poland by Kruszyna and Richter sought to determine whether with increased cold ischemic times (CIT) and increased use of extended criteria donors (ECD), would hypothermic machine perfusion (HMP) still have the potential to improve outcomes in kidney...
Hypothermic Machine Perfusion in Liver Transplantation — A Randomized Trial
In a multicenter, randomized, controlled trial by Van Rijn, et al, they sought to compare hypothermic oxygenated machine perfusion with static cold storage in liver transplantation from donation after cardiac death (DCD) donors. In this trial, they included 156...
What factors are associated with delayed graft function in a Brazilian cohort?
A multicenter retrospective study by de Sandes-Freitas et al. sought to determine the national rate of delayed graft function (DGF) and the associated risk factors with DGF. They studied 8,657 single deceased donor kidney transplants between January 2014 and December...